TY - JOUR
T1 - Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients
AU - Van de Glind, Geurt
AU - van den Brink, Wim
AU - Koeter, Maarten W.J.
AU - Carpentier, Pieter Jan
AU - van Emmerik-van Oortmerssen, Katelijne
AU - Kaye, Sharlene
AU - Skutle, Arvid
AU - Bu, Eli Torild H.
AU - Franck, Johan
AU - Konstenius, Maija
AU - Moggi, Franz
AU - Dom, Geert
AU - Verspreet, Sofie
AU - Demetrovics, Zsolt
AU - Kapitány-Fövény, Máté
AU - Fatséas, Melina
AU - Auriacombe, Marc
AU - Schillinger, Arild
AU - Seitz, Andrea
AU - Johnson, Brian
AU - Faraone, Stephen V.
AU - Ramos-Quiroga, J. Antoni
AU - Casas, Miguel
AU - Allsop, Steve
AU - Carruthers, Susan
AU - Barta, Csaba
AU - Schoevers, Robert A.
AU - Levin, Frances R.
PY - 2013/10/1
Y1 - 2013/10/1
N2 - Background: To detect attention deficit hyperactivity disorder (ADHD) in treatment seeking substance use disorders (SUD) patients, a valid screening instrument is needed. Objectives: To test the performance of the Adult ADHD Self-Report Scale V 1.1(ASRS) for adult ADHD in an international sample of treatment seeking SUD patients for DSM-IV-TR; for the proposed DSM-5 criteria; in different subpopulations, at intake and 1-2 weeks after intake; using different scoring algorithms; and different externalizing disorders as external criterion (including adult ADHD, bipolar disorder, antisocial and borderline personality disorder). Methods: In 1138 treatment seeking SUD subjects, ASRS performance was determined using diagnoses based on Conner's Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as gold standard. Results: The prevalence of adult ADHD was 13.0% (95% CI: 11.0-15.0%). The overall positive predictive value (PPV) of the ASRS was 0.26 (95% CI: 0.22-0.30), the negative predictive value (NPV) was 0.97 (95% CI: 0.96-0.98). The sensitivity (0.84, 95% CI: 0.76-0.88) and specificity (0.66, 95% CI: 0.63-0.69) measured at admission were similar to the sensitivity (0.88, 95% CI: 0.83-0.93) and specificity (0.67, 95% CI: 0.64-0.70) measured 2 weeks after admission. Sensitivity was similar, but specificity was significantly better in patients with alcohol compared to (illicit) drugs as the primary substance of abuse (0.76 vs. 0.56). ASRS was not a good screener for externalizing disorders other than ADHD. Conclusions: The ASRS is a sensitive screener for identifying possible ADHD cases with very few missed cases among those screening negative in this population. © 2013 Elsevier Ireland Ltd.
AB - Background: To detect attention deficit hyperactivity disorder (ADHD) in treatment seeking substance use disorders (SUD) patients, a valid screening instrument is needed. Objectives: To test the performance of the Adult ADHD Self-Report Scale V 1.1(ASRS) for adult ADHD in an international sample of treatment seeking SUD patients for DSM-IV-TR; for the proposed DSM-5 criteria; in different subpopulations, at intake and 1-2 weeks after intake; using different scoring algorithms; and different externalizing disorders as external criterion (including adult ADHD, bipolar disorder, antisocial and borderline personality disorder). Methods: In 1138 treatment seeking SUD subjects, ASRS performance was determined using diagnoses based on Conner's Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as gold standard. Results: The prevalence of adult ADHD was 13.0% (95% CI: 11.0-15.0%). The overall positive predictive value (PPV) of the ASRS was 0.26 (95% CI: 0.22-0.30), the negative predictive value (NPV) was 0.97 (95% CI: 0.96-0.98). The sensitivity (0.84, 95% CI: 0.76-0.88) and specificity (0.66, 95% CI: 0.63-0.69) measured at admission were similar to the sensitivity (0.88, 95% CI: 0.83-0.93) and specificity (0.67, 95% CI: 0.64-0.70) measured 2 weeks after admission. Sensitivity was similar, but specificity was significantly better in patients with alcohol compared to (illicit) drugs as the primary substance of abuse (0.76 vs. 0.56). ASRS was not a good screener for externalizing disorders other than ADHD. Conclusions: The ASRS is a sensitive screener for identifying possible ADHD cases with very few missed cases among those screening negative in this population. © 2013 Elsevier Ireland Ltd.
KW - Addiction
KW - ADHD
KW - ASRS
KW - Attention/deficit hyperactivity disorder
KW - Prevalence
KW - Psychiatry
KW - Substance use disorders
KW - Validity
U2 - 10.1016/j.drugalcdep.2013.04.010
DO - 10.1016/j.drugalcdep.2013.04.010
M3 - Article
SN - 0376-8716
VL - 132
SP - 587
EP - 596
JO - Drug and Alcohol Dependence
JF - Drug and Alcohol Dependence
IS - 3
ER -